New BMC Biology study shows SPOT-MAS multi-omics cfDNA distinguishes early-stage breast cancer from benign lesions with high specificity.

The Gene Solutions research team, in collaboration with Ho Chi Minh City Oncology Hospital and several oncology centers, has published new peer-reviewed data in BMC Biology demonstrating that a multimodal